Benserazide Hydrochloride (CAS 14919-77-8) Comprehensive User Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Detailed Applications & Mechanisms
- 3. Clinical & Industrial Usage Scenarios
- 4. Customer Case Studies
- 5. Technical Inquiry & Purchasing Guidance
1. Product Specifications & Comparative Analysis
| Parameter | Benserazide HCl | Carbidopa |
|---|---|---|
| CAS Number | 14919-77-8 | 28860-95-9 |
| Molecular Formula | C10H15N3O5·HCl | C10H14N2O4 |
| Molecular Weight | 293.7 g/mol | 226.23 g/mol |
| Purity | ≥98% (HPLC) | ≥99% |
Key Advantage: Superior peripheral decarboxylase inhibition with 2:1 optimal L-DOPA ratio vs Carbidopa’s 4:1 ratio.
2. Detailed Applications & Mechanisms
2.1 Pharmaceutical Applications
As a peripheral aromatic L-amino acid decarboxylase (AADC) inhibitor, Benserazide HCl:
- Enhances L-DOPA bioavailability by 70-80% in Parkinson’s therapy
- Reduces peripheral dopamine conversion by 90%
- Enables lower L-DOPA dosages (typical ratio 4:1 L-DOPA:Benserazide)
2.2 Research Applications
- Neuropharmacology studies: Dopaminergic pathway analysis
- Enzyme inhibition kinetics (IC50 = 15 nM for AADC)
- Metabolic pathway mapping in preclinical models
3. Clinical & Industrial Usage Scenarios
3.1 Pharmaceutical Manufacturing
Standard formulation process:
- Combine with L-DOPA in 1:4 ratio (Benserazide:L-DOPA)
- Tablet compression at 15-20 kN force
- Coating with hydroxypropyl methylcellulose (HPMC)
3.2 Research Protocols
Experimental dosing guidelines:
| Model | Dosage | Administration |
|---|---|---|
| Rodent studies | 12.5 mg/kg | Oral, bid |
| In vitro assays | 10-100 μM | Co-incubation |
4. Customer Case Studies
4.1 NeuroPharm Solutions Ltd. (UK)
Challenge: Reduce L-DOPA-induced nausea in Phase II trial
Solution: 100 mg Benserazide HCl + 400 mg L-DOPA daily
Outcome: 62% reduction in GI adverse events vs previous formulation
4.2 University Research Team (Germany)
Study: Dopamine metabolism in zebrafish models
Protocol: 0.5 mM Benserazide in embryo medium
Finding: 40% increase in CNS dopamine retention
5. Technical Inquiry & Purchasing Guidance
For batch-specific COA, custom formulations, or bulk pricing:
Email: info@vivalr.com
Tel: (86) 15866781826
Procurement Checklist:
1. Required quantity (grams/kg)
2. Purity requirements
3. Preferred shipment method
4. Regulatory documentation needs



评论
目前还没有评论。